Literature DB >> 20080771

Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis.

Randall J Olsen1, Izabela Sitkiewicz, Ara A Ayeras, Vedia E Gonulal, Concepcion Cantu, Stephen B Beres, Nicole M Green, Benfang Lei, Tammy Humbird, Jamieson Greaver, Ellen Chang, Willie P Ragasa, Charles A Montgomery, Joiner Cartwright, Allison McGeer, Donald E Low, Adeline R Whitney, Philip T Cagle, Terry L Blasdel, Frank R DeLeo, James M Musser.   

Abstract

Single-nucleotide changes are the most common cause of natural genetic variation among members of the same species, but there is remarkably little information bearing on how they alter bacterial virulence. We recently discovered a single-nucleotide mutation in the group A Streptococcus genome that is epidemiologically associated with decreased human necrotizing fasciitis ("flesh-eating disease"). Working from this clinical observation, we find that wild-type mtsR function is required for group A Streptococcus to cause necrotizing fasciitis in mice and nonhuman primates. Expression microarray analysis revealed that mtsR inactivation results in overexpression of PrsA, a chaperonin involved in posttranslational maturation of SpeB, an extracellular cysteine protease. Isogenic mutant strains that overexpress prsA or lack speB had decreased secreted protease activity in vivo and recapitulated the necrotizing fasciitis-negative phenotype of the DeltamtsR mutant strain in mice and monkeys. mtsR inactivation results in increased PrsA expression, which in turn causes decreased SpeB secreted protease activity and reduced necrotizing fasciitis capacity. Thus, a naturally occurring single-nucleotide mutation dramatically alters virulence by dysregulating a multiple gene virulence axis. Our discovery has broad implications for the confluence of population genomics and molecular pathogenesis research.

Entities:  

Mesh:

Year:  2010        PMID: 20080771      PMCID: PMC2818956          DOI: 10.1073/pnas.0911811107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

Review 1.  A decade of molecular pathogenomic analysis of group A Streptococcus.

Authors:  James M Musser; Samuel A Shelburne
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

2.  Enhanced secretory production of a single-chain antibody fragment from Bacillus subtilis by coproduction of molecular chaperones.

Authors:  S C Wu; R Ye; X C Wu; S C Ng; S L Wong
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

3.  Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease.

Authors:  E H Burns; A M Marciel; J M Musser
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

4.  Severe group a streptococcal soft-tissue infections in Ontario: 1992-1996.

Authors:  Abdu Sharkawy; Donald E Low; Raphael Saginur; Daniel Gregson; Benjamin Schwartz; Peter Jessamine; Karen Green; Allison McGeer
Journal:  Clin Infect Dis       Date:  2002-01-07       Impact factor: 9.079

5.  Inactivation of Streptococcus pyogenes extracellular cysteine protease significantly decreases mouse lethality of serotype M3 and M49 strains.

Authors:  S Lukomski; S Sreevatsan; C Amberg; W Reichardt; M Woischnik; A Podbielski; J M Musser
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

6.  Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci.

Authors:  M D Svensson; D A Scaramuzzino; U Sjöbring; A Olsén; C Frank; D E Bessen
Journal:  Mol Microbiol       Date:  2000-10       Impact factor: 3.501

7.  Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections.

Authors:  Stephen B Beres; Gail L Sylva; Daniel E Sturdevant; Chanel N Granville; Mengyao Liu; Stacy M Ricklefs; Adeline R Whitney; Larye D Parkins; Nancy P Hoe; Gerald J Adams; Donald E Low; Frank R DeLeo; Allison McGeer; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-28       Impact factor: 11.205

8.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

9.  A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin.

Authors:  V Kapur; S Topouzis; M W Majesky; L L Li; M R Hamrick; R J Hamill; J M Patti; J M Musser
Journal:  Microb Pathog       Date:  1993-11       Impact factor: 3.738

10.  Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection.

Authors:  C F Kuo; J J Wu; K Y Lin; P J Tsai; S C Lee; Y T Jin; H Y Lei; Y S Lin
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more
  59 in total

1.  Increased Pilus Production Conferred by a Naturally Occurring Mutation Alters Host-Pathogen Interaction in Favor of Carriage in Streptococcus pyogenes.

Authors:  Anthony R Flores; Randall J Olsen; Concepcion Cantu; Kyler B Pallister; Fermin E Guerra; Jovanka M Voyich; James M Musser
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

2.  Growth phase-dependent modulation of Rgg binding specificity in Streptococcus pyogenes.

Authors:  Srivishnupriya Anbalagan; Alexander Dmitriev; W Michael McShan; Paul M Dunman; Michael S Chaussee
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

3.  Cooking with GAS.

Authors:  Matthew Holden
Journal:  Nat Rev Microbiol       Date:  2010-04       Impact factor: 60.633

4.  Naturally occurring single amino acid replacements in a regulatory protein alter streptococcal gene expression and virulence in mice.

Authors:  Ronan K Carroll; Samuel A Shelburne; Randall J Olsen; Bryce Suber; Pranoti Sahasrabhojane; Muthiah Kumaraswami; Stephen B Beres; Patrick R Shea; Anthony R Flores; James M Musser
Journal:  J Clin Invest       Date:  2011-04-01       Impact factor: 14.808

5.  Polymorphisms in Regulator of Cov Contribute to the Molecular Pathogenesis of Serotype M28 Group A Streptococcus.

Authors:  Paul E Bernard; Priyanka Kachroo; Jesus M Eraso; Luchang Zhu; Jessica E Madry; Sarah E Linson; Matthew Ojeda Saavedra; Concepcion Cantu; James M Musser; Randall J Olsen
Journal:  Am J Pathol       Date:  2019-07-29       Impact factor: 4.307

6.  Asymptomatic carriage of group A streptococcus is associated with elimination of capsule production.

Authors:  Anthony R Flores; Brittany E Jewell; Randall J Olsen; Samuel A Shelburne; Nahuel Fittipaldi; Stephen B Beres; James M Musser
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

7.  Natural variant of collagen-like protein a in serotype M3 group a Streptococcus increases adherence and decreases invasive potential.

Authors:  Anthony R Flores; Brittany E Jewell; Erika M Versalovic; Randall J Olsen; Beth A Bachert; Slawomir Lukomski; James M Musser
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

8.  A Single Amino Acid Replacement in the Sensor Kinase LiaS Contributes to a Carrier Phenotype in Group A Streptococcus.

Authors:  Anthony R Flores; Brittany E Jewell; Dedipya Yelamanchili; Randall J Olsen; James M Musser
Journal:  Infect Immun       Date:  2015-08-17       Impact factor: 3.441

9.  Adaptation of group A Streptococcus to human amniotic fluid.

Authors:  Izabela Sitkiewicz; Nicole M Green; Nina Guo; Ann M Bongiovanni; Steven S Witkin; James M Musser
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

Review 10.  Stress Physiology of Lactic Acid Bacteria.

Authors:  Konstantinos Papadimitriou; Ángel Alegría; Peter A Bron; Maria de Angelis; Marco Gobbetti; Michiel Kleerebezem; José A Lemos; Daniel M Linares; Paul Ross; Catherine Stanton; Francesca Turroni; Douwe van Sinderen; Pekka Varmanen; Marco Ventura; Manuel Zúñiga; Effie Tsakalidou; Jan Kok
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-27       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.